Clinical Outcomes of Molecular Tumor Boards: A Systematic Review.
Kara L LarsonBin HuangHeidi L WeissPamela Carmen HullPhilip M WestgateRachel W MillerSusanne M ArnoldJill M KolesarPublished in: JCO precision oncology (2021)
Although data quality is limited by a lack of prospective randomized controlled trials, MTBs appear to improve clinical outcomes for patients with cancer. Future research should concentrate on prospective trials and standardization of approach and outcomes.